Frequent mutations in tumor suppressor genes (e.g., p53 and p16), defects in DNA repair pathways, and chromosomal abnormalities such as trisomy 3p collectively establish a tumor‐prone phenotype, predisposing survivors to both lymphoid malignancies and a spectrum of solid tumors [16]. The gene discussed is TP53; the disease is neoplasm.